MRS 2211, identified by its CAS number 1197030-56-0, is a chemical compound that belongs to the class of selective serotonin receptor antagonists. It is primarily studied for its potential applications in neuroscience and pharmacology, particularly in the context of modulating serotonin signaling pathways. The compound exhibits high affinity for specific serotonin receptors, which may influence various physiological and psychological processes. MRS 2211 is often utilized in research to explore its effects on mood regulation, anxiety, and other neuropsychiatric conditions. Its chemical structure and properties allow for interactions with biological systems, making it a valuable tool in understanding serotonin's role in the central nervous system. As with many research chemicals, safety and handling precautions are essential, as the full spectrum of its biological effects and potential toxicity may not be completely understood. Further studies are necessary to elucidate its mechanisms of action and therapeutic potential.

MRS 2211

1197030-56-0: MRS 2211, identified by its CAS number 1197030-56-0, is a chemical compound that belongs to the class of selective serotonin receptor antagonists. It is primarily studied for its potential applications in neuroscience and pharmacology, particularly in the context of modulating serotonin signaling pathways. The compound exhibits high affinity for specific serotonin receptors, which may influence various physiological and psychological processes. MRS 2211 is often utilized in research to explore its effects on mood regulation, anxiety, and other neuropsychiatric conditions. Its chemical structure and properties allow for interactions with biological systems, making it a valuable tool in understanding serotonin's role in the central nervous system. As with many research chemicals, safety and handling precautions are essential, as the full spectrum of its biological effects and potential toxicity may not be completely understood. Further studies are necessary to elucidate its mechanisms of action and therapeutic potential.

MRS 2211 is a potent inhibitor of polysaccharides that has been shown to induce apoptosis in cancer cells. It is a Chinese analog of adenosine and acts as an antagonist to the A3 adenosine receptor. MRS 2211 has been found to be effective against various types of tumors, including breast, lung, and colon cancer. This inhibitor blocks the action of protein kinase B (AKT), which is involved in cell survival and proliferation. MRS 2211 also inhibits the growth of cancer cells by decreasing the levels of anti-apoptotic proteins and increasing pro-apoptotic proteins. Additionally, it has been shown to reduce tumor growth in mice models and may have potential as an anticancer drug. Its presence can be detected in urine samples, making it a useful tool for monitoring its effectiveness in cancer treatment.

CAS 1197030-56-0

MRS 2211

MRS 2211

Ref: 3D-XXB03056